Chinook sets up China joint venture SanReno to tackle kidney diseases; BeyondSpring, Everest, Zai Lab - News of the day
Elise Mak · 12/02/2021
Kidney disease biotech Chinook Therapeutics has set up a joint venture called SanReno Therapeutics with an investor syndicate led by Frazier Healthcare Partners and Pivotal bioVenture Partners Chinam, and more news from BeyondSpring, Everest, Zai Lab and ITabMed.
Everest partners with AbCellera to gain antibodies for up to 10 targets
Sarina Yang · 09/24/2021
​Everest Medicines and AbCellera entered a multi-year collaboration to discover therapeutic antibodies for up to 10 targets selected by Everest. This is the third deal Everest disclosed in two weeks.
After mRNA, Everest gains BTK inhibitor in $561M deal to fight renal diseases
Elise Mak · 09/17/2021
Everest will pay Suzhou Sinovent and SinoMab BioScience up to $561 million to license the global rights to BTK inhibitor XNW1011, four days after the mRNA transaction with Providence that is worth over $500 million.
Copyright © 2016-2021 PharmaDJ .All Rights Reserved.   Suggestions and feedback:   Record/License No.:沪ICP备17054709号-1  
About PharmaDJ | Subscription | Contact Us | Copyright Statement